Optimum Investment Advisors boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Rating) by 21.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 850 shares of the exchange traded fund’s stock after acquiring an additional 150 shares during the period. Optimum Investment Advisors’ holdings in SPDR S&P Biotech ETF were worth $71,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Jane Street Group LLC raised its holdings in SPDR S&P Biotech ETF by 111.4% in the second quarter. Jane Street Group LLC now owns 172,730 shares of the exchange traded fund’s stock worth $12,829,000 after buying an additional 1,682,382 shares during the last quarter. Two Sigma Advisers LP purchased a new position in SPDR S&P Biotech ETF in the third quarter worth about $105,480,000. Brown Advisory Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 1,107.6% during the third quarter. Brown Advisory Inc. now owns 970,255 shares of the exchange traded fund’s stock valued at $76,960,000 after purchasing an additional 889,912 shares during the last quarter. Two Sigma Investments LP purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $52,621,000. Finally, Castleark Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $47,822,000.
SPDR S&P Biotech ETF Stock Down 2.2 %
XBI opened at $76.50 on Friday. The firm has a 50 day moving average price of $84.76 and a 200-day moving average price of $82.59. SPDR S&P Biotech ETF has a twelve month low of $61.78 and a twelve month high of $97.19. The stock has a market capitalization of $7.19 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Get a free copy of the StockNews.com research report on SPDR S&P Biotech ETF (XBI)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Rating).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
